{"originalText": "，患者2012年底开始出现接触性出血，2013年4月曾行宫颈细胞学检查及HPV检查未发现异常（未见单），2014年8月我院门诊就诊，，TCT:镜上见异型腺细胞，考虑为腺癌。遂行（宫颈肿物）活检术，，术后病理：镜检为低分化癌。妇科检查可见宫颈下唇可见结节状肿物约3X2.5CM，考虑“宫颈癌IB1期”，于2014-09-16在行“宫颈癌根治术(II型子宫切除+两侧附件切除+盆腔淋巴结清扫术+腹主动脉旁淋巴结活检术）”。，术后病检结果示：（全子宫+两附件）镜检为宫颈低分化癌，结合免疫组化结果，符合低分化腺鳞癌，浸润宫颈及宫颈管浅肌层（&LT;1/2肌层），未累及阴道穹窿及子宫体上段；未见明确脉管内癌栓及神经束侵犯。淋巴结未见肿瘤转移。术后于2014-09-25、2014-10-21予TP方案（紫杉醇+顺铂）化疗2程，下次化疗结束后白细胞最低达2.1×109/L，予瑞白升白治疗后血常规恢复正常。今再次返院化疗入院。患者起病以来，精神可，无呕吐，入睡好，阴道无流血，二便正常，体重无明显改变。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 97, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 107, "end_pos": 111}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "手术", "overlap": 0, "start_pos": 164, "end_pos": 207}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 248, "end_pos": 254}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 348}, {"end_pos": 354, "label_type": "药物", "overlap": 0, "start_pos": 352}, {"end_pos": 386, "label_type": "药物", "overlap": 0, "start_pos": 384}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}]}
